It has expanded its offerings to include weight loss, focusing on prescription medications, including its own compounded semaglutide glucagon-like peptide-1 (GLP-1) medication
The PlexusDx Precision Peptide Genetic Test analyzes GLP1R, and GIPR variants that relate to GLP-1 and related signaling pathways
Until now, there have been no robust, peer-reviewed, clinical trials that ensure the safety, efficacy, and long-term outcomes of microdosing GLP-1 medications
It should include: Nutrition Hydration Resistance training Strength Mobility Falls Daily function Quality of life The goal is not merely weight loss
When to Contact Your Healthcare Provider While self-injections are generally straightforward, certain situations warrant professional guidance
The most frequent side effects are a GI nightmare: nausea (up to half of users!), vomiting, diarrhea, constipation, abdominal pain